Navigation Links
ZeptoMetrix™ Releases New Respiratory Verification Panel for Molecular Quality Control
Date:7/2/2019

ZeptoMetrix™ Corporation (ZMC) has released a new 20-member respiratory verification panel for use in laboratories engaged in utilizing molecular diagnostics technologies when testing for infectious diseases.

“Our focus is to provide both strategic collaborators and end-use customers with reliable, easy-to-use, and cost-effective external QC controls for their various laboratory needs”, explains Shawn R. Smith, President and CEO of ZeptoMetrix. “As industry leaders such as QIAGEN® gain approval to market novel approaches to testing for infectious diseases, such as the QIAstat-Dx® syndromic testing system, we seek to develop versatile tools that assist in the effort to ensure optimal performance within the testing labs. The recent release of our NATtrol™ Respiratory Verification Panel (# NATRVP-QIA) provides such laboratories with another example of how ZeptoMetrix is focused on supporting the diagnostic testing community with an ever-expanding portfolio of industry-leading products.”

About ZeptoMetrix™
ZeptoMetrix Corporation (ZMC) is an established industry leader in the design, development, and delivery of innovative, quality solutions to the Infectious Disease Diagnostics Market. Our expertise and abilities in Molecular Diagnostics, including External Quality Controls, Verification Panels, Proficiency Panels, Customized and OEM Products/Services have set the industry standard for performance and reliability and made ZeptoMetrix the preferred choice for independent 3rd party QC materials.

Founded in 1999, ZeptoMetrix is headquartered in Buffalo, NY with additional facilities in Franklin, Massachusetts.

About NATtrol™
Globally, millions of people are tested for infectious diseases each year. The implications of reporting either a false positive or a false negative can be devastating to the patient. Accurate and sensitive diagnostics are necessary to confirm that laboratories are providing patients with proper testing results. Utilizing ZeptoMetrix NATtrol QC materials on a consistent basis helps to monitor testing performance and enhance confidence in testing results.

ZeptoMetrix NATtrol Molecular Diagnostics products are an essential component of today’s ever-evolving testing market and are designed to provide safe, accurate and cost-effective support for activities relating to the analysis and identification of possible disease-causing microorganisms. The patented ZeptoMetrix NATtrol process renders highly-purified microorganisms non-infectious while allowing internal nucleic acids to remain intact, thereby serving as an ideal reference material for molecular diagnostic testing applications. Representing a total process control, from DNA extraction through amplification and eventual detection, NATtrol products are ready-to-use, refrigerator stable, and safe for operators to handle.

The routine and repetitive use of NATtrol™ External Run Controls and Verification Panels help enable laboratories to monitor performance and identify trends in daily test variations, test kit lot changes, and among individual operators.

For Sales and/or information regarding ZeptoMetrix, NATtrol Molecular Quality Controls & Panels, and Development/Custom Services, please contact ZeptoMetrix Customer Service.

Contact:
ZeptoMetrix Corporation, Customer Service
878 Main Street
Buffalo, NY 14202
716-882-0920
custserv(at)zeptometrix(dot)com
http://www.zeptometrix.com

Media:
Michael Hershfield, Vice President, Sales & Marketing                            
508-553-5852
mhershfield(at)zeptometrix(dot)com

Read the full story at https://www.prweb.com/releases/zeptometrix_releases_new_respiratory_verification_panel_for_molecular_quality_control/prweb16397083.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine news :

1. ZeptoMetrix™ Corporation (ZMC) Releases FDA Class 1 Exempt, IVD and CE Labeled NATtrol™ RP Multimarker Controls
2. Clean Cooking Alliance Releases 2018 Annual Report Focusing on Investment, Innovation, and Impact
3. FSH Society Releases White Paper on Clinical Trial Readiness
4. American Academy of Thermology (AAT) Releases Full Agenda for 2019 Annual Meeting & Scientific Session Sep. 7-8 in Atlanta, GA
5. Emerald Shores Author Releases, GROW: An Awareness Journal
6. Point-of-Care Partners Releases In-Depth Report Advising Healthcare Stakeholders How to Reduce Frictional Costs, Improve Time to Therapy, and Succeed with ePA
7. Edens Garden Releases 7 New Baking Soda-Free Deodorant Aromas To The Shop
8. Cognition® Corporation Releases Second Paper on ISO 13485
9. Paso Robles Dentist, Lisa Lu Davis, DMD, Releases a Report About Preventing Toothaches
10. MCG Health Releases 23rd Edition of Industry-Leading Care Guidelines
11. Cantata Health Releases 2019 Predictions Surrounding the Future of Acute Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/11/2019)... ... 11, 2019 , ... American Family Care , the ... expanding its long-term partnership with 919 Marketing , a national content marketing ... 200 locations across the country, American Family Care (AFC) is enlisting 919 Marketing’s ...
(Date:11/9/2019)... ... November 08, 2019 , ... The Women’s Dermatologic Society (WDS) ... health concerns. The WDS Board of Directors appointed Molly Hinshaw, MD to fill the ... current March 2019-March 2020 term and will be presented to the membership as the ...
(Date:11/7/2019)... ... 06, 2019 , ... Atlantic Ultraviolet Corporation makes it their business to fight ... shot. Since the flu season starts in October until March, Atlantic Ultraviolet makes it ... can simply sign-up and get their shot. , Ann Wysocki, COO of Atlantic Ultraviolet ...
(Date:11/7/2019)... ... November 07, 2019 , ... Understanding UDI in EU Device ... https://www.fdanews.com/understandudi , Are EU device and IV diagnostics sales in jeopardy? , ... regulations —UDI — is ahead, and many device and diagnostics makers simply aren’t prepared. ...
(Date:11/6/2019)... ... November 06, 2019 , ... ... plan market, announced today that 94% of the health insurance plans receiving the ... Medicaid health insurance plans, use SPH solutions according to reports recently released ...
Breaking Medicine News(10 mins):
(Date:11/11/2019)... ... November 11, 2019 , ... MAPS and ... implementation of joint projects for the benefit of biomedical professionals in the ... professionals to leverage their roles in the research, development, and commercialization activities ...
(Date:11/11/2019)... ... November 11, 2019 , ... ... growing drug class and have a major impact in the oncology field. ... still need to be overcome. Among these, defining valuable and adapted combination ...
(Date:11/11/2019)... Ohio (PRWEB) , ... November 10, 2019 , ... ... the rebranding alongside a redesign of its website , which features over ... transpired from the brand's 35+ year commitment to providing high-quality health and wellness ...
Breaking Medicine Technology: